Science and technology innovation, technological progress, is the life of the hospital, is the source of hospital development. In the development and construction of the hospital, they have been unswervingly science and education as the foundation of the hospital, strong hospital, and with strong measures and means to implement and promote.
In the hospital's carefully planned three five-year plan, all the science and education on the core position. The active development of key technologies and the timely convening of the Science and Technology Award Conference have greatly mobilized the enthusiasm of medical staff for scientific and technological innovation, and the hospital has ushered in the spring of scientific and technological development.
More than 200 new technology projects have been introduced one after another in various specialties and developed healthily. Among them, interventional radiology technology has been widely used in clinical practice. Every year, more than a thousand cases of coronary endoluminal angioplasty, coronary stenting, cerebrovascular interventional technology, ultrasound interventional technology, tumor interventional technology can be carried out. Among them, the stent implantation technology for multiple cerebrovascular stenosis fills the blank of this technology in Jilin Province.
Series of laparoscopic technology shows strong strength. In addition to laparoscopy, it also carries out a number of series of cavity technology such as hysteroscopy, choledochoscopy, duodenoscopy, arthroscopy, nephroscopy and so on. Among them, nasal endoscopic surgery has accounted for more than 90% of otolaryngological surgery, gynecological laparoscopic surgery has accounted for more than 80% of gynecological surgery, and Holmium laser ureteroscopy and nephrolithoscopy stone treatment technology to fill the gap in the province.
The research and development and application of stem cells have opened up a broad prospect of stem cell transplantation. The hospital not only invested heavily in building a modern stem cell production base in line with GMP standards, but has now successfully developed bone marrow mesenchymal stem cells, umbilical cord-derived mesenchymal stem cells, amniotic membrane stem cells, tumor immune cells and embryonic neural stem cells with independent intellectual property rights. Stem cell transplantation technology has already achieved remarkable efficacy and breakthroughs in the treatment of cerebral thrombosis, cerebral hemorrhage, sequelae of traumatic brain injury, paraplegia, cerebral palsy, cirrhosis of the liver, uremia, and malignant tumors, attracting a large number of patients both at home and abroad to seek medical treatment. Among them, "Basic Research on Stem Cell Transplantation to Intervene in the Changes of Matrix Enzymes in Rats with Liver Fibrosis" has been established in the Department of Health of Jilin Province. Research on Mechanisms Related to Percutaneous Umbilical Cord-derived Mesenchymal Stem Cell Transplantation for the Treatment of Bone Discontinuities" won the 2009 Science and Technology Progress Award in Jilin Province. At present, many hospitals in and out of the province are applying the stem cells produced by the Stem Cell Laboratory of the Center Hospital to carry out clinical treatment.